Aerie Pharmaceuticals Reports Topline Result from Rhopressa Mechanism of Action Study

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...

Pharma Trends 2017: FDA Pushes Creation of More Generic Drugs

INN takes a look at some of the major stories and developments in the pharma industry during 2017.

Q Biomed Comments on its Glaucoma Drug and Industry News in the Ophthalmology Space

Q BioMed Inc. (OTCQB:QBIO), a biotechnology acceleration company with a glaucoma drug in development through its partner Mannin Research provides...

5 Top NASDAQ Biotech Stocks: Tobira Therapeutics Gains 752 Percent

Last week's top gainer was Tobira Therapeutics, followed by Northwest Biotherapeutics, Sarepta Therapeutics, Novavax and Galectin Therapeutics.

5 Top NASDAQ Biotech Stocks: Aerie Pharmaceuticals Up 73 Percent

Last week's top gainer was Aerie Pharmaceuticals, followed by Acasti Pharma, Alphatec Holdings, Northwest Biotherapeutics and Stellar Biotechnologies

Aerie Pharmaceuticals Sees Stock Soar

It’s been called a stock to watch—and the performance of Aerie Pharmaceuticals has left some investors wide-eyed in recent days....